What is he best known for?
The fields of study he is best known for:
- Enzyme
- Gene
- Internal medicine
Dennis W. Choi mainly investigates Glutamate receptor, Neuroscience, NMDA receptor, Kainate receptor and Neurotoxicity.
His Glutamate receptor research is multidisciplinary, incorporating perspectives in Extracellular, Biophysics, Immunology, Neuron and Glutamic acid.
The study incorporates disciplines such as Excitotoxicity, Receptor, Calcium and Ischemia in addition to Neuroscience.
His work carried out in the field of NMDA receptor brings together such families of science as Endocrinology, Superoxide dismutase, Electrophysiology and Pharmacology.
His studies in Kainate receptor integrate themes in fields like Agonist, Metabotropic glutamate receptor and Neurotoxin.
His study brings together the fields of Nitric oxide and Neurotoxicity.
His most cited work include:
- Glutamate neurotoxicity and diseases of the nervous system (4216 citations)
- Excitotoxic cell death (2051 citations)
- THE ROLE OF GLUTAMATE NEUROTOXICITY IN HYPOXIC- ISCHEMIC NEURONAL DEATH (2011 citations)
What are the main themes of his work throughout his whole career to date?
Glutamate receptor, NMDA receptor, Neuroscience, Neurotoxicity and Pharmacology are his primary areas of study.
His Glutamate receptor research incorporates elements of Extracellular, Cell biology and Endocrinology.
His research integrates issues of Apoptosis, Programmed cell death and Neuroprotection in his study of NMDA receptor.
His Neuroscience study combines topics from a wide range of disciplines, such as Excitotoxicity, Hypoxia and Ischemia.
Dennis W. Choi combines subjects such as Neurotoxin, Nitric oxide and Glutamic acid with his study of Neurotoxicity.
The various areas that Dennis W. Choi examines in his Pharmacology study include Antagonist and Toxicity.
He most often published in these fields:
- Glutamate receptor (40.00%)
- NMDA receptor (38.80%)
- Neuroscience (33.60%)
What were the highlights of his more recent work (between 2000-2020)?
- Neuroprotection (20.00%)
- Internal medicine (23.20%)
- Cell biology (18.80%)
In recent papers he was focusing on the following fields of study:
Dennis W. Choi focuses on Neuroprotection, Internal medicine, Cell biology, NMDA receptor and Endocrinology.
His Neuroprotection research incorporates themes from Stroke, Ischemic stroke and Ischemia.
His Cell biology research integrates issues from Apoptosis, Biochemistry and Trk receptor.
His work in the fields of Excitotoxicity overlaps with other areas such as Population and Aromatase.
His Excitotoxicity research includes themes of Neuroscience and Central nervous system.
He works mostly in the field of Glutamate receptor, limiting it down to topics relating to Brain damage and, in certain cases, AMPA receptor, as a part of the same area of interest.
Between 2000 and 2020, his most popular works were:
- Ion homeostasis and apoptosis. (326 citations)
- Calcium and Excitotoxic Neuronal Injury (315 citations)
- Metabotropic Glutamate Receptor 1-Induced Upregulation of NMDA Receptor Current: Mediation through the Pyk2/Src-Family Kinase Pathway in Cortical Neurons (189 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
Dennis W. Choi spends much of his time researching Cell biology, Internal medicine, Endocrinology, Neuroprotection and Intracellular.
The Cell biology study combines topics in areas such as Apoptosis and Programmed cell death.
His Internal medicine study focuses mostly on Tyrosine phosphorylation, NMDA receptor, Calcium and Patch clamp.
His research in Neuroprotection focuses on subjects like Anesthesia, which are connected to Stroke, Neurodegeneration, Cerebral infarction and Neurotoxicity.
Intracellular is a subfield of Biochemistry that Dennis W. Choi explores.
His Src family kinase study incorporates themes from Excitotoxicity, Glutamate receptor, Metabotropic glutamate receptor 1 and Metabotropic glutamate receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
